Disparities in US Lung Cancer Clinical Trial Enrollment.

Background: Disparities within clinical trial enrollment are well-documented, reducing the generalizability of results. Although nearly 30 years have passed since Congress passed the NIH Revitalization Act to encourage the participation of minoritized populations in clinical trials, these patients c...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Racial & Ethnic Health Disparities Vol. 11; no. 5; pp. 3201 - 3210
Autores principales: Kilic, Seyda, Zhao, Jenny, Okut, Hayrettin, Jani, Chinmay T., Radwan, Amr, Dudipala, Harshitha, Burns, Laura, Tapan, Umit
Formato: research tables/charts Journal Article
Publicado: Springer Nature Oct2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180269192&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 180269192
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        21973792
        GQHQ
      jtl: Journal of Racial & Ethnic Health Disparities
      issn: 21973792
      maglogo: N
    pubinfo:
      dt: Oct2024
      vid: 11
      iid: 5
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        180269192
        171299572
        180269192
        180269192
        10.1007/s40615-023-01776-2
        180269192
      ppf: 3201
      ppct: 9
      formats:
      tig:
        atl: Disparities in US Lung Cancer Clinical Trial Enrollment.
      aug:
        au:
          Kilic, Seyda
          Zhao, Jenny
          Okut, Hayrettin
          Jani, Chinmay T.
          Radwan, Amr
          Dudipala, Harshitha
          Burns, Laura
          Tapan, Umit
        affil: https://ror.org/05wvpxv85 School of Arts and Sciences, Tufts University, Medford, MA, USA
      sug:
        subj:
          Lung Neoplasms Therapy
          Research Subject Recruitment Trends
          Patient Selection Trends
          Healthcare Disparities United States
          Ethnic Groups Psychosocial Factors
          Race Factors
          Sex Factors
          Age Factors
          Clinical Trials Trends
          Human
          Cancer Patients
          Male
          Female
          Aged
          Consent (Research)
          United States
          Socioeconomic Disparities in Health
          Cancer Patients Psychosocial Factors
          Research Subjects Psychosocial Factors
          National Institutes of Health (U.S.)
          Clinical Trial Registry
          Registries, Disease
          T-Tests
          Kruskal-Wallis Test
          Medically Underserved
          Racism
          Sexism
          Comparative Studies
          Health Services Accessibility
          Descriptive Statistics
          Multiple Regression
          Data Analysis Software
          Aged: 65+ years
          Male
          Female
      ab: Background: Disparities within clinical trial enrollment are well-documented, reducing the generalizability of results. Although nearly 30 years have passed since Congress passed the NIH Revitalization Act to encourage the participation of minoritized populations in clinical trials, these patients continue to be underrepresented. This study aimed to investigate lung cancer clinical trial enrollment disparities for race/ethnicity, sex, and age. Methods: We queried the National Institutes of Health: US National Library of Medicine database of clinical trials for all US-based lung cancer clinical trials completed between 2004 and 2021 and collected data on race and ethnicity, gender, and age breakdown. This data was compared to Surveillance, Epidemiology, and End Results (SEER) database data. Independent sample t-tests and Kruskal–Wallis's approach were used to analyze the data. Results: Of 311 eligible trials with exclusive US enrollment, 136 (44%) reported race and ethnicity breakdown for the patient cohort representing 9869 patients. Hispanic, Non-Hispanic American Indian/Alaska Native, Non-Hispanic Black, and Non-Hispanic Unreported participants were underrepresented (p = 0.001, p = 0.005, p = 0.014, p = 0.002, respectively). Non-Hispanic White participants were overrepresented (p = 0.018). Disparities worsened from 2017 to 2021 for Hispanic patients (p = 0.03). No significant differences were found for sex or age. Conclusions: Disparities for clinical lung cancer trial enrollment have not shown statistically significant improvement since 2004, and representation remains unequal, especially for racial and ethnic minorities.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N